Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spain: "Radiotherapy dosing is key" in cancer strategy:

This article was originally published in Clinica

Executive Summary

A carefully tailored combination of radiotherapy and chemotherapy is the best strategy for treating cancer. So agreed experts across the two fields, at the end of the first International Chemo/Radiotherapy Symposium, held in Elche (Alicante) last month. The event was hosted by Spain's medical oncology (SEOM), radiotherapeutic oncology (AERO) and cancer research (ASEICA) societies, with a view to developing optimal cancer care strategies. Careful dosification and monitoring is crucial to achieving the successes that combination therapies have demonstrated in improving cure rates and minimising damage to organ function and tissue, said AERO president Dr Manuel de las Heras.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts